top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Kristen Marie Williams net worth and biography

Kristen Williams Biography and Net Worth

Insider of Pacira BioSciences

Kristen Williams worked with the company as a legal consultant before joining as Corporate Counsel in December 2011. Since then, she has been promoted to Vice President, General Counsel in 2013 and to Chief Administrative Officer, General Counsel and Secretary in 2014. Prior to joining Pacira, she was Vice President, Corporate Compliance and Assistant General Counsel for Bioenvision, Inc from June 2004 until its merger with Genzyme Corporation in 2007. From September 1999 to June 2004, she practiced corporate law at Paul Hastings LLP in New York, where her practice encompassed all aspects of public and private mergers and acquisitions, corporate finance, and securities law and compliance, with a core focus in the healthcare industry.

Ms. Williams earned a Bachelor of Science Degree in Business Administration from Bucknell University and a J.D. Degree from the University of Denver, College of Law in Denver, CO.

What is Kristen Marie Williams' net worth?: The estimated net worth of Kristen Marie Williams is at least $657,212.50 as of June 14th, 2023. Ms. Williams owns 25,375 shares of Pacira BioSciences stock worth more than $657,213 as of April 25th. This net worth evaluation does not reflect any other investments that Ms. Williams may own. Additionally, Ms. Williams receives a salary of $799,630.00 as Insider at Pacira BioSciences. Learn More about Kristen Marie Williams' net worth.
How old is Kristen Marie Williams?: Ms. Williams is currently 50 years old. There are 6 older executives and no younger executives at Pacira BioSciences. The oldest executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who is 74 years old. Learn More on Kristen Marie Williams' age.
What is Kristen Marie Williams' salary?: As the Insider of Pacira BioSciences, Inc., Ms. Williams earns $799,630.00 per year. The highest earning executive at Pacira BioSciences is Mr. David M. Stack, Advisor, who commands a salary of $1,540,000.00 per year. Learn More on Kristen Marie Williams' salary.
How do I contact Kristen Marie Williams?: The corporate mailing address for Ms. Williams and other Pacira BioSciences executives is 5 SYLVAN WAY SUITE 300, PARSIPPANY NJ, 07054. Pacira BioSciences can also be reached via phone at (813) 553-6680 and via email at [email protected]. Learn More on Kristen Marie Williams' contact information.
Has Kristen Marie Williams been buying or selling shares of Pacira BioSciences?: Kristen Marie Williams has not been actively trading shares of Pacira BioSciences in the last ninety days. Most recently, Kristen Marie Williams sold 6,467 shares of the business's stock in a transaction on Wednesday, June 14th. The shares were sold at an average price of $37.03, for a transaction totalling $239,473.01. Following the completion of the sale, the insider now directly owns 25,375 shares of the company's stock, valued at $939,636.25. Learn More on Kristen Marie Williams' trading history.
Who are Pacira BioSciences' active insiders?: Pacira BioSciences' insider roster includes Donald Manning (Insider), Max Reinhardt (Insider), Charles Reinhart, III (CFO), Lauren Riker (VP), David Stack (CEO), Andreas Wicki (Director), Kristen Williams (Insider), and Roy Winston (Insider). Learn More on Pacira BioSciences' active insiders.
Are insiders buying or selling shares of Pacira BioSciences?: In the last twelve months, insiders at the sold shares 16 times. They sold a total of 138,857 shares worth more than $4,613,719.15. The most recent insider tranaction occured on March, 8th when Director Gary W Pace sold 90,000 shares worth more than $2,754,000.00. Insiders at Pacira BioSciences own 6.6% of the company. Learn More about insider trades at Pacira BioSciences.
Information on this page was last updated on 3/8/2024.

Kristen Marie Williams Insider Trading History at Pacira BioSciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2023	Sell	6,467	$37.03	$239,473.01	25,375
3/21/2022	Sell	7,253	$72.67	$527,075.51
2/25/2022	Sell	2,050	$67.02	$137,391.00
2/16/2022	Sell	10	$65.00	$650.00
2/4/2022	Sell	1,000	$65.18	$65,180.00
1/21/2022	Sell	200	$65.41	$13,082.00
1/18/2022	Sell	23,440	$65.26	$1,529,694.40
6/10/2021	Sell	5,689	$59.60	$339,064.40	27,957
4/13/2021	Sell	21,823	$66.95	$1,461,049.85	27,387
9/16/2020	Sell	27,853	$60.14	$1,675,079.42	30,719
6/4/2020	Sell	2,402	$46.33	$111,284.66	16,791
8/14/2019	Sell	6,252	$39.49	$246,891.48
6/4/2019	Sell	2,529	$42.91	$108,519.39	19,845
8/14/2018	Sell	4,773	$47.04	$224,521.92	22,374
6/4/2018	Sell	2,040	$33.02	$67,360.80	19,272
11/17/2017	Sell	10,000	$40.00	$400,000.00	23,455
8/15/2017	Sell	3,461	$36.75	$127,191.75	21,312
6/5/2017	Sell	1,877	$43.32	$81,311.64	13,773
5/15/2017	Sell	21,041	$50.86	$1,070,145.26	18,775
6/6/2016	Sell	600	$47.20	$28,320.00	6,900

Kristen Marie Williams Buying and Selling Activity at Pacira BioSciences

Pacira BioSciences Company Overview

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

Today's Range

Now: $25.77

$25.33

$26.00

50 Day Range

MA: $28.85

$25.90

$31.41

2 Week Range

Now: $25.77

$25.33

$48.60

Volume

122,072 shs

Average Volume

489,660 shs

Market Capitalization

$1.20 billion

P/E Ratio

31.81

Dividend Yield

N/A

Beta

0.76

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

Kristen Williams Biography and Net Worth

What is Kristen Marie Williams' net worth?

How old is Kristen Marie Williams?

What is Kristen Marie Williams' salary?

How do I contact Kristen Marie Williams?

Has Kristen Marie Williams been buying or selling shares of Pacira BioSciences?

Who are Pacira BioSciences' active insiders?

Are insiders buying or selling shares of Pacira BioSciences?